Document is current
Any future updates will be listed below
-
Authors
Burkhardt, Gerrit https://orcid.org/0000-0003-3965-5664
Blackwell, Simon E. https://orcid.org/0000-0002-3313-7084
Chen, Miaoxi https://orcid.org/0009-0007-3991-153X
Feldmann, Lisa https://orcid.org/0009-0002-3404-2869
Björklund, Jonas https://orcid.org/0000-0003-2521-6679
Dechantsreiter, Esther https://orcid.org/0009-0002-0674-4572
Bulubas, Lucia https://orcid.org/0000-0002-5797-8742
Goerigk, Stephan https://orcid.org/0000-0002-3021-0346
Keeser, Daniel https://orcid.org/0000-0002-0244-1024
Falkai, Peter https://orcid.org/0000-0003-2873-8667
Greimel, Ellen https://orcid.org/0000-0002-9916-9230
Bechmann, Peter
Schulte-Körne, Gerd https://orcid.org/0000-0002-9960-1572
Hasan, Alkomiet https://orcid.org/0000-0002-2662-9742
Strube, Wolfgang https://orcid.org/0000-0003-2380-7651
Padberg, Frank https://orcid.org/0000-0001-7638-8310
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EE2303A)
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 21 May 2024
Accepted: 2 October 2024
First Online: 10 October 2024
Declarations
:
: GB, SB, MC, LF, JB, AK, ED, LB, SG, DK, EG, PB, and GS report no competing interests. WS has received a paid speakership from Mag & More (neurocare), Recordati and Rovi. He was member of advisory boards of Recordati, Janssen and Boehringer Ingelheim. Invitations to conferences or other activities were not accepted. AH is editor of the German (DGPPN) schizophrenia treatment guidelines, first author of the WFSBP schizophrenia treatment guidelines; on advisory boards of and speaker fees from AbbVie (speaker fees only), Advanz (speaker fees only), Janssen-Cilag, Lundbeck, Recordati, Rovi, and Otsuka. PF received research support/honoraria for lectures or advisory activities from Boehringer-Ingelheim, Janssen, Lundbeck, Otsuka, Recordati and Richter; he has received and is currently receiving grants from several national and international foundations and institutions, e.g. from the “German Science Foundation”, the “German Ministry of Science” and the “German Ministry of Health”. FP has received grants from the German Research Foundation (BR 4264/6–1) and the German Federal Ministry of Education and Research (01EW1903); consulting fees from Brainsway (Jerusalem, Israel) as a member of the European Scientific Advisory Board and from Sooma (Helsinki, Finland) as a member of the International Scientific Advisory Board; honoraria for workshops from Mag&More (Munich, Germany) and honoraria for lectures from the NeuroCare Group and Brainsway; and has received equipment from Mag&More, the NeuroCare Group, and Brainsway.
